Allosteric modulation of nicotinic acetylcholine receptors

Biochemical Pharmacology

Volumn 74, Issue 8, 2007, Pages 1155-1163

  Bertrand, Daniel ^a   Gopalakrishnan, Murali ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Allosteric modulation; Nicotinic acetylcholine receptor

Indexed keywords

5 HYDROXYINDOLE; ALPHA4 BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR; BUNGAROTOXIN RECEPTOR; DIZOCILPINE; GALANTAMINE; GENISTEIN; IVERMECTIN; LY 2087101; NICOTINIC RECEPTOR; NS 1738; PNU 120596; THIAZOLE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ALLOSTERISM; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR BINDING;

ALLOSTERIC REGULATION; ANIMALS; BINDING SITES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; RECEPTORS, NICOTINIC;

EID: 34548677767     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.07.011     Document Type: Article

References (53)

1. Monod J., Wyman J., and Changeux J.P. On the nature of allosteric transitions: a plausible model. J Mol Biol 12 (1965) 88-118
2. Karlin A. On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine. J Theor Biol 16 (1967) 306-320
3. Changeux J.P., and Edelstein S.J. Allosteric mechanisms of signal transduction. Science 308 (2005) 1424-1428
4. Dani J.A., and Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47 (2007) 699-729
5. Jensen A.A., Frolund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem 48 (2005) 4705-4745
6. Romanelli M.N., Gratteri P., Guandalini L., Martini E., Bonaccini C., and Gualtieri F. Central nicotinic receptors: structure, function, ligands, and therapeutic potential. Chem Med Chem 2 (2007) 746-767
7. Le Novere N., and Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J Mol Evol 40 (1995) 155-172
8. Yu C.R., and Role L.W. Functional contribution of the alpha7 subunit to multiple subtypes of nicotinic receptors in embryonic chick sympathetic neurones. J Physiol 509 Pt 3 (1998) 651-665
9. Khiroug S.S., Harkness P.C., Lamb P.W., Sudweeks S.N., Khiroug L., Millar N.S., et al. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol 540 (2002) 425-434
10. Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Millar N., et al. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 5 (1990) 847-856
11. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., and Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383 (1996) 713-716
12. 2+ permeability of nicotinic acetylcholine receptors in rat hippocampal CA1 interneurones. J Physiol 566 (2005) 759-768
13. Castro N.G., and Albuquerque E.X. alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophys J 68 (1995) 516-524
14. Drisdel R.C., and Green W.N. Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers. J Neurosci 20 (2000) 133-139
15. Bertrand D., Galzi J.L., Devillers-Thiery A., Bertrand S., and Changeux J.P. Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proc Natl Acad Sci USA 90 (1993) 6971-6975
16. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13 (1993) 596-604
17. Changeux J.P., and Edelstein S.J. Allosteric receptors after 30 years. Neuron 21 (1998) 959-980
18. Chemouilli P., Heidmann T., Changeux J.P., Bachy A., and Morre M. Allosteric effects of diprobutine on acetylcholine receptors. Eur J Pharmacol 117 (1985) 205-214
19. Heidmann T., and Changeux J.P. Characterization of the transient agonist-triggered state of the acetylcholine receptor rapidly labeled by the noncompetitive blocker [3H]chlorpromazine: additional evidence for the open channel conformation. Biochemistry 25 (1986) 6109-6113
20. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der Oost J., Smit A.B., et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411 (2001) 269-276
21. Brejc K., van Dijk W.J., Smit A.B., and Sixma T.K. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor. Novartis Found Symp 245 (2002) 22-29 discussion 9-32, 165-8
22. Celie P.H., Kasheverov I.E., Mordvintsev D.Y., Hogg R.C., van Nierop P., van Elk R., et al. Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant. Nat Struct Mol Biol 12 (2005) 582-588
23. Shi J., Koeppe J.R., Komives E.A., and Taylor P. Ligand-induced conformational changes in the acetylcholine-binding protein analyzed by hydrogen-deuterium exchange mass spectrometry. J Biol Chem 281 (2006) 12170-12177
24. Taly A., Corringer P.J., Grutter T., Prado de Carvalho L., Karplus M., and Changeux J.P. Implications of the quaternary twist allosteric model for the physiology and pathology of nicotinic acetylcholine receptors. Proc Natl Acad Sci USA 103 (2006) 16965-16970
25. Xiu X., Hanek A.P., Wang J., Lester H.A., and Dougherty D.A. A unified view of the role of electrostatic interactions in modulating the gating of Cys loop receptors. J Biol Chem 280 (2005) 41655-41666
26. Lee W.Y., and Sine S.M. Principal pathway coupling agonist binding to channel gating in nicotinic receptors. Nature 438 (2005) 243-247
27. Lummis S.C., Beene D.L., Lee L.W., Lester H.A., Broadhurst R.W., and Dougherty D.A. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438 (2005) 248-252
28. Revah F., Bertrand D., Galzi J.L., Devillers-Thiery A., Mulle C., Hussy N., et al. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature 353 (1991) 846-849
29. Bertrand D., Devillers-Thiery A., Revah F., Galzi J.L., Hussy N., Mulle C., et al. Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc Natl Acad Sci USA 89 (1992) 1261-1265
30. Galzi J.L., Devillers-Thiery A., Hussy N., Bertrand S., Changeux J.P., and Bertrand D. Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature 359 (1992) 500-505
31. Krause R.M., Buisson B., Bertrand S., Corringer P.J., Galzi J.L., Changeux J.P., et al. Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53 (1998) 283-294
32. Zwart R., De Filippi G., Broad L.M., McPhie G.I., Pearson K.H., Baldwinson T., et al. 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Neuropharmacology 43 (2002) 374-384
33. Charpantier E., Wiesner A., Huh K.H., Ogier R., Hoda J.C., Allaman G., et al. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci 25 (2005) 9836-9849
34. Lopes C., Pereira E.F., Wu H.Q., Puranik P., Njar V., Schwarcz R., et al. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at {alpha}7* nicotinic receptors. J Pharmacol Exp Ther (2007)
35. Popa R.V., Pereira E.F., Lopes C., Maelicke A., and Albuquerque E.X. The N-butylcarbamate derivative of galantamine acts as an allosteric potentiating ligand on alpha7 nicotinic receptors in hippocampal neurons: clinical implications for treatment of Alzheimer's disease. J Mol Neurosci 30 (2006) 227-232
36. Broad L.M., Zwart R., Pearson K.H., Lee M., Wallace L., McPhie G.I., et al. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators. J Pharmacol Exp Ther 318 (2006) 1108-1117
37. Gronlien J.H., Haakerud M., Ween H., Thorin-Hagene K., Briggs C.A., Gopalakrishnan M., et al. Distinct profiles of {alpha}7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Mol Pharmacol 72 (2007) 715-724
38. Galzi J.L., Bertrand S., Corringer P.J., Changeux J.P., and Bertrand D. Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor. EMBO J 15 (1996) 5824-5832
39. Chimienti F., Hogg R.C., Plantard L., Lehmann C., Brakch N., Fischer J., et al. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum Mol Genet 12 (2003) 3017-3024
40. Conroy W.G., Liu Q.S., Nai Q., Margiotta J.F., and Berg D.K. Potentiation of alpha7-containing nicotinic acetylcholine receptors by select albumins. Mol Pharmacol 63 (2003) 419-428
41. Faghih R., Gfesser G., and Gopalakrishnan M. Advances in the discovery of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor. Recent Patents CNS Drug Discovery 2 (2007) 99-106
42. Ng H.J., Whittemore E.R., Tran M.B., Hogenkamp D.J., Broide R.S., Johnstone T.B., et al. Nootropic {alpha}7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc Natl Acad Sci USA 104 (2007) 8059-8064
43. Timmermann D.B., Grønlien J.H., Kohlhaas K.L., Nielsen EØ, Dyhring T., Ahring P.K., et al. An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition enhancing properties in vivo. J Pharmacol Exp Ther (2007) 10.1124/ jpet.107.120436
44. Hansen S.B., and Taylor P. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors. J Mol Biol 369 (2007) 895-901
45. Hurst R.S., Hajos M., Raggenbass M., Wall T.M., Higdon N.R., Lawson J.A., et al. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci 25 (2005) 4396-4405
46. Kohlhaas K.L., Bitner R.S., Robb H., Radek R., Markosyan S., and Gopalakrishnan M. Improved preattention and short-term memory via positive allosteric modulation of the α7 neuronal nicotinic receptor. Int J Neuropsychopharmacol 9 Suppl 1 (2006) S202
47. Buisson B., and Bertrand D. Allosteric modulation of neuronal nicotinic acetylcholine receptors. J Physiol Paris 92 (1998) 89-100
48. Bertrand D., Valera S., Bertrand S., Ballivet M., and Rungger D. Steroids inhibit nicotinic acetylcholine receptors. Neuroreport 2 (1991) 277-280
49. Valera S., Ballivet M., and Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 89 (1992) 9949-9953
50. Curtis L., Buisson B., Bertrand S., and Bertrand D. Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Mol Pharmacol 61 (2002) 127-135
51. Paradiso K., Zhang J., and Steinbach J.H. The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid. J Neurosci 21 (2001) 6561-6568
52. Hsiao B., Dweck D., and Luetje C.W. Subunit-dependent modulation of neuronal nicotinic receptors by zinc. J Neurosci 21 (2001) 1848-1856
53. Hsiao B., Mihalak K.B., Repicky S.E., Everhart D., Mederos A.H., Malhotra A., et al. Determinants of zinc potentiation on the alpha4 subunit of neuronal nicotinic receptors. Mol Pharmacol 69 (2006) 27-36